Challenges for clinical application of "TRACEBACK" study: testing of historical Tubo-Ovarian cancer patients for hereditary risk genes.

Ann Transl Med · 2023 · PMC10170281 · PMID 37181337

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In the case of t BRCA m, approximately 80% of them have germline BRCA pathogenic variants (g BRCA m), thus it would be highly significant to notify relatives of the t BRCA m results ( 21 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.